Clark Capital Management Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $103M | Sell |
474,417
-128,376
| -21% | -$28.5M | 0.64% | 33 |
|
|
2025
Q4 | $138M | Sell |
602,793
-92,598
| -13% | -$21.1M | 0.85% | 25 |
|
|
2025
Q3 | $161M | Buy |
695,391
+90,508
| +15% | +$18.4M | 1.01% | 15 |
|
|
2025
Q2 | $112M | Buy |
604,883
+33,163
| +6% | +$6.16M | 0.78% | 28 |
|
|
2025
Q1 | $120M | Buy |
571,720
+567,818
| +14,552% | +$110M | 0.86% | 22 |
|
|
2024
Q4 | $693K | Buy |
3,902
+173
| +5% | +$31.8K | ﹤0.01% | 319 |
|
|
2024
Q3 | $736K | Sell |
3,729
-4,441
| -54% | -$829K | 0.01% | 313 |
|
|
2024
Q2 | $1.4M | Buy |
8,170
+3,263
| +66% | +$541K | 0.01% | 258 |
|
|
2024
Q1 | $894K | Sell |
4,907
-637
| -11% | -$110K | 0.01% | 291 |
|
|
2023
Q4 | $859K | Sell |
5,544
-5,345
| -49% | -$779K | 0.01% | 284 |
|
|
2023
Q3 | $1.62M | Buy |
10,889
+197
| +2% | +$28.9K | 0.02% | 232 |
|
|
2023
Q2 | $1.44M | Sell |
10,692
-825
| -7% | -$121K | 0.01% | 241 |
|
|
2023
Q1 | $1.84M | Sell |
11,517
-280,334
| -96% | -$42.9M | 0.02% | 217 |
|
|
2022
Q4 | $47.2M | Buy |
291,851
+10,257
| +4% | +$1.57M | 0.43% | 53 |
|
|
2022
Q3 | $37.8M | Buy |
281,594
+10,897
| +4% | +$1.56M | 0.5% | 49 |
|
|
2022
Q2 | $41.5M | Sell |
270,697
-108,981
| -29% | -$16.7M | 0.54% | 43 |
|
|
2022
Q1 | $61.5M | Buy |
379,678
+9,742
| +3% | +$1.42M | 0.69% | 28 |
|
|
2021
Q4 | $50.1M | Buy |
369,936
+5,705
| +2% | +$674K | 0.61% | 41 |
|
|
2021
Q3 | $39.3M | Buy |
364,231
+120,309
| +49% | +$13.7M | 0.54% | 54 |
|
|
2021
Q2 | $27.5M | Buy |
243,922
+227,236
| +1,362% | +$25.6M | 0.39% | 101 |
|
|
2021
Q1 | $1.81M | Sell |
16,686
-2,790
| -14% | -$298K | 0.03% | 224 |
|
|
2020
Q4 | $2.09M | Sell |
19,476
-4,231
| -18% | -$407K | 0.03% | 224 |
|
|
2020
Q3 | $2.08M | Buy |
23,707
+93
| +0.4% | +$8.76K | 0.04% | 212 |
|
|
2020
Q2 | $2.32M | Buy |
23,614
+1,137
| +5% | +$100K | 0.04% | 197 |
|
|
2020
Q1 | $1.71M | Sell |
22,477
-2,131
| -9% | -$182K | 0.04% | 181 |
|
|
2019
Q4 | $2.18M | Buy |
24,608
+312
| +1% | +$25.9K | 0.05% | 182 |
|
|
2019
Q3 | $1.84M | Sell |
24,296
-3,463
| -12% | -$237K | 0.04% | 188 |
|
|
2019
Q2 | $2.02M | Sell |
27,759
-292
| -1% | -$23K | 0.04% | 184 |
|
|
2019
Q1 | $2.26M | Sell |
28,051
-454,415
| -94% | -$37.2M | 0.05% | 179 |
|
|
2018
Q4 | $44.5M | Sell |
482,466
-965
| -0.2% | -$84.9K | 1.2% | 21 |
|
|
2018
Q3 | $45.7M | Sell |
483,431
-63,593
| -12% | -$6.03M | 1.16% | 19 |
|
|
2018
Q2 | $50.7M | Buy |
547,024
+247,387
| +83% | +$24.2M | 1.46% | 11 |
|
|
2018
Q1 | $28.4M | Sell |
299,637
-287,218
| -49% | -$31.6M | 0.89% | 34 |
|
|
2017
Q4 | $56.8M | Buy |
586,855
+93
| +0% | +$8.77K | 1.74% | 7 |
|
|
2017
Q3 | $52.1M | Buy |
586,762
+31,056
| +6% | +$2.36M | 1.76% | 8 |
|
|
2017
Q2 | $40.3M | Buy |
555,706
+89,355
| +19% | +$6.01M | 1.57% | 6 |
|
|
2017
Q1 | $30.4M | Buy |
466,351
+251,803
| +117% | +$15.8M | 1.35% | 11 |
|
|
2016
Q4 | $13.4M | Sell |
214,548
-14,011
| -6% | -$855K | 0.7% | 43 |
|
|
2016
Q3 | $14.4M | Buy |
228,559
+74,934
| +49% | +$4.85M | 0.83% | 32 |
|
|
2016
Q2 | $9.51M | Buy |
153,625
+143,446
| +1,409% | +$8.74M | 0.62% | 57 |
|
|
2016
Q1 | $581K | Sell |
10,179
-9,369
| -48% | -$522K | 0.05% | 214 |
|
|
2015
Q4 | $1.16M | Sell |
19,548
-99,486
| -84% | -$5.73M | 0.09% | 162 |
|
|
2015
Q3 | $6.48M | Sell |
119,034
-41,601
| -26% | -$2.71M | 0.58% | 54 |
|
|
2015
Q2 | $10.8M | Buy |
160,635
+70,722
| +79% | +$4.62M | 0.99% | 25 |
|
|
2015
Q1 | $5.26M | Sell |
89,913
-65,496
| -42% | -$3.96M | 0.48% | 64 |
|
|
2014
Q4 | $10.2M | Buy |
155,409
+12,863
| +9% | +$811K | 0.93% | 27 |
|
|
2014
Q3 | $8.23M | Buy |
142,546
+2,512
| +2% | +$139K | 0.71% | 33 |
|
|
2014
Q2 | $7.9M | Buy |
140,034
+2,367
| +2% | +$124K | 0.66% | 45 |
|
|
2014
Q1 | $7.08M | Sell |
137,667
-52,277
| -28% | -$2.64M | 0.61% | 48 |
|
|
2013
Q4 | $10M | Buy |
189,944
+7,424
| +4% | +$365K | 0.83% | 21 |
|
|
2013
Q3 | $8.16M | Buy |
182,520
+12,598
| +7% | +$558K | 0.65% | 34 |
|
|
2013
Q2 | $7.03M | Buy |
+169,922
| New | +$7.43M | 0.65% | 33 |
|
Other funds holding ABBV
VCM
VPM
Clark Capital Management Group's ABBV Position: Q1 2026 in Review
Clark Capital Management Group reduced its AbbVie (ABBV) stake by 21% in Q1 2026, selling an estimated $28.5M and leaving 474,417 shares worth $103M. The position accounts for 0.64% of the portfolio, ranked #33.
Clark Capital Management Group first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $161M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Clark Capital Management Group held 474,417 shares of AbbVie worth $103M as of Q1 2026.
- Clark Capital Management Group sold 128,376 AbbVie shares in Q1 2026, an estimated $28.5M.
- AbbVie made up 0.64% of Clark Capital Management Group's portfolio in Q1 2026, its #33 holding.
- Clark Capital Management Group first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Clark Capital Management Group's AbbVie position peaked at $161M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.